---
title: "Cobenfy (xanomeline and trospium chloride) in schizophrenia: Drug interactions questions"
description: "Drug interactions questions on Cobenfy (xanomeline and trospium chloride) in schizophrenia, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What drug interactions does COBENFY have? 1 question quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/cobenfy--schizophrenia/drug-interactions"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Cobenfy (xanomeline and trospium chloride) in schizophrenia: Drug interactions questions

Manufacturer: Bristol-Myers Squibb Company  
Prescribing information: [Cobenfy](https://packageinserts.bms.com/pi/pi_cobenfy.pdf)

## Drug interactions

<a id="cobenfy-drug-interactions"></a>

### What drug interactions does COBENFY have?

> “COBENFY has no contraindicated medications<sup>1</sup>:
>
> Antimuscarinic drugs in combination with COBENFY may increase frequency and/or severity of anticholinergic side effects<sup>1-3</sup>
>
> Examples of commonly used drugs*:
>
> Benztropine Diphenhydramine Hydroxyzine”

Source: [COBENFY: Dosing COBENFY™ (xanomeline and trospium chloride) | For HCPs, captured 2026-11-08](https://www.cobenfyhcp.com/dosing#:~:text=COBENFY%20has%20no%20contraindicated,Benztropine%20Diphenhydramine%20Hydroxyzine)

> “*	This is not an exhaustive list of medications and is only used to show select examples from each category.”

Source: [COBENFY: Dosing COBENFY™ (xanomeline and trospium chloride) | For HCPs, captured 2026-11-08](https://www.cobenfyhcp.com/dosing#:~:text=This%20is%20not%20an%20exhaustive,select%20examples%20from%20each%20category.)

> “Drugs Eliminated by Active Tubular Secretion: Monitor for increased frequency and/or 
> severity of adverse reactions related to COBENFY and to drugs eliminated by active tubular 
> secretion. (7.1)
> 	• Strong CYP2D6 Inhibitors: Monitor for increased frequency and/or severity of COBENFY-
> related adverse reactions. (7.1)
> 	• Sensitive Substrates of CYP3A4 or P-glycoprotein: Monitor for increased frequency and/or 
> severity of adverse reactions from these substrates. (7.1)
> 	• Antimuscarinic Drugs: Monitor for increased frequency or severity of anticholinergic 
> adverse reactions. (7.2)”

Source: [COBENFY: Prescribing information, page 1, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_cobenfy.pdf#page=1)

> “Effects on Absorption of Drugs: COBENFY may potentially alter the absorption of some concomitantly administered drugs due to anticholinergic effects on gastrointestinal motility. Dosage adjustment of concomitant medications may be necessary based on clinical response and tolerability.<sup>1</sup>
>
> Additional Consideration: Anticholinergics (muscarinic antagonists) and muscarinic agonists may affect the pharmacological activity of one another.”

Source: [COBENFY: Dosing COBENFY™ (xanomeline and trospium chloride) | For HCPs, captured 2026-11-08](https://www.cobenfyhcp.com/dosing#:~:text=Effects%20on%20Absorption%20of%20Drugs%3A,pharmacological%20activity%20of%20one%20another.)

## Related pages
- [Medical information: Cobenfy (xanomeline and trospium chloride): Schizophrenia](https://www.evicenter.com/medical-information/cobenfy--schizophrenia)
- [Indication](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/safety)
- [Specific populations](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/access-and-coverage)
